Preclinical evaluation of the RBD-Trimeric vaccine: A novel approach to strengthening biotechnological sovereignty in developing countries against SARS-CoV-2 variants

New immunogens against emerging new virus variants are essential for controlling new variants. Methods: A preclinical study in which a receptor-binding domain (RBD) trimer was designed in silico with information from the Beta (B.1.351), Omicron (BA.5), and Wuhan 1 variant. A three-dimensional model...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Luis Flórez, Daniel Echeverri-De la Hoz, Alfonso Calderón, Hector Serrano-Coll, Caty Martinez, Camilo Guzmán, Bertha Gastelbondo, German Arrieta, Ariel Arteta, Tania Márquez, Ricardo Rivero, Salim Máttar
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Elsevier 2025-03-01
Serie:	Travel Medicine and Infectious Disease
Soggetti:	Public health Biotechnology Social development Computational biology Preventive medicine Vulnerable populations
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1477893925000262
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!